NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
1Y Forward Revenue growth
422.2%
1Y Forward EPS growth
N/A
Last EPS & EPS Surprise
($0.54)
6.5% beat
Last 10 Earnings
10 Beat / 0 Miss
PTGX Revenue and EPS Expectations
Crunching data... Almost there!
PTGX Earnings Surprises
Crunching data... Almost there!
PTGX Earnings History
Crunching data... Almost there!
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
1. What is Protagonist Therapeutics, Inc. (PTGX) 1-year forward revenue growth estimate?
Protagonist Therapeutics, Inc. (PTGX) 1-year forward revenue growth is estimated at 422.2%.
2. What is Protagonist Therapeutics, Inc. (PTGX) 1-year forward EPS growth estimate?
Protagonist Therapeutics, Inc. (PTGX) 1-year forward EPS growth is estimated at N/A.
3. What was Protagonist Therapeutics, Inc. (PTGX) last EPS, and was there a surprise?
Protagonist Therapeutics, Inc. (PTGX) last reported EPS was ($0.54), with a 6.5% beat.
4. What is Protagonist Therapeutics, Inc. (PTGX) performance across the last 10 earnings reports?
Protagonist Therapeutics, Inc. (PTGX) had 10 beats and 0 misses in its last 10 earnings reports.